MediSpend’s legal experts recently presented a webinar shedding light on the recent transparency updates within the life science industry. The presentation covered key topics, such as updates to CMS’ Open Payments reporting, various state considerations and the newly issued OIG General Compliance Program Guidance. Notably, the webinar highlighted recent developments in compliance regulations in both Italy and […]
Discover how MediSpend’s third-party due diligence solution helps life sciences companies streamline compliance, reduce costs and gain 360-degree visibility into their third-party networks.
Download the information sheet to learn how automated workflows, global risk screening and a user-friendly portal can simplify your due diligence process and keep your business audit-ready.
MediSpend’s Chief Commercial Officer, Seth Houston, walks through the top six transparency reporting challenges and provides solutions to overcome those challenges.
On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders.
During the […]
MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Connecticut’s new sales representative disclosure requirements and an update on the Italian Sunshine Act.
Numerous updates to […]
The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records for previous program years.
The 2022 publication includes transactions that took place between January 1st and December 31st. Applicable manufacturers reported $12.59 billion in reportable payments, ownership and investment interests to healthcare […]
MediSpend’s Suj Patel and Frank Madden discuss ways to get and stay ahead of global transparency reporting obligations.
Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they contract and engage with to ensure they are not caught off guard by any infractions that exist, a process known as sanctions screening. Sanctions screening involves verifying these individuals and entities […]
Recently, MediSpend’s Advisory Services team presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Oregon’s new sales representative disclosure requirements, the Italian Sunshine Act and the Chilean Chamber of Pharmaceutical Innovation (CIF) disclosure […]
At MediSpend, we’re on a mission to empower life sciences companies to grow their business compliantly through our best-in-class software solutions and top-rated client services. To achieve this mission, we’ve assembled an incredible team and have laid a foundation of cultural attributes that help us make a difference in the life sciences industry.
Each year, MediSpend […]
